I recommend Frank, his skills and his organization for any medium to long-term financing efforts in the life science arena.
(Dr. Jessen, Bionamics)
Investor Relations & PR
TBTP provides comprehensive IR/PR services with the goal to maximize awareness for our clients. Our specialists and consultants with years of industry experience include senior IR professionals with marketing and communications expertise writing business analysis’ for leading international publications.
TBTP provides senior advice gathered from years of real experience within the fields of Healthcare, Life Sciences and Biotechnology. With almost 30 years of experience Frank Rothmaier established relationships with a broad network of institutional investors, family offices, hedge funds, asset managers, analysts, venture capital decision-makers and ultra-high net worth individuals. Designing investment cases for companies with complex products, technologies and services is our daily bread.
TBTP’s meetings are designed to achieve maximum results. We are a specialist in raising brand awareness in Europe organizing tailor-made, high impact one-on-one meetings only with quality attendees throughout Germany, Switzerland and other key global financial locations. Media presentations are also an excellent way to effectively leverage the client’s time and budget.
In today’s ultra-competitive environment many emerging managers and companies find it difficult to get to the key decision makers and present them with their pitch. We are a strong believer in focused approach to real investors and therefor will place you and your company in front of potential interest and money, helping match investors with your company based on mutual goals and industry familiarity. This differentiates us from other providers in our peer group.
More and more companies from North America, Asia and Australia are choosing to dual-list their stock in Germany. In order to maximize the exposure of your company to potential local investors our investment banking network ensures that regular research is made available. Contact TBTP if you are interested in a listing of your company in Europe. We are here to answer any questions you may have.
Business New – Financial News – New York Stock Exchange — Wall Street — CEO Interview — 2016
Clinical services specialist Ergomed Plc (LON:ERGO) has announced that its co-development partner…
Watch more →
The Swiss Biotech Day has long become the standard annual get-together of the Swiss biopharmaceutical industry. And Basel, as one of the most vivid cities in terms of biotechnological and pharmaceutical research, development and production, proved to be the ideal location.
All events →
Within only a couple of weeks and the 24/7 support of Frank, Formycon AG completed its capital increase successfully
(Dr. Combe, CFO Formycon)
Frank always delivered what he was promising and was always available when needed.
(Dr. Muster, Avir Biotechnologies)
Frank was in constant contact to ensure the transactions’s success throughout the progress. We respect him for his professionalism and found him to be of highest integrity
(Darrell Brookstein, Executive VP, Stellar Bio.)